Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement

Dana-Farber Cancer Institute125 enrolled

Overview

The purpose of this research is to understand how screening for patient resource needs followed by customized resource matching can improve outcomes for adults with breast, lung or gastrointestinal cancer.

This research study is an intervention assessment; this is the first-time investigators are examining the impact of screening for resource needs followed by customized resource matching at Dana-Farber Cancer Institute. * The research study procedures include screening for social determinants of health (resource) needs and, depending on study group, resource matching. * Participants will be randomized into one of two groups. * Usual Care or Usual Care with customized resource matching. It is expected that about 125 participants will take part in this research study.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

125

Conditions

Breast Cancer Lung Cancer Gastrointestinal Cancer

Interventions

Resource MatchingOTHER

Resource staff involved in the customized resource matching arm of the intervention will include staff from DFCI Patient Services and DFCI Financial Counseling. Financial counseling will support patients with financial resource needs. DFCI Patient Services will provide assistance for all other patient Social Determinants of Health needs.

Usual CareOTHER

Patients randomized to the control group will receive a pre-existing pamphlet detailing DFCI resources.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Eligible patients will be adults age 18 or older, able to consent, scheduled for a new patient consultation in DFCI BOC, TOP or GCC. To select for patients from demographic groups vulnerable to SDoH needs, two different groups will be eligible to participate. * Group A * BIPOC (Black, Latinx, Native American or Pacific Islander) * LEP Spanish-speaking (As indicated by the EHR) * Low SES (from zip code with median household income \<$32,000/year) OR * Age 70+ * Group B * Any one NPIQ response indicating SDoH need * Health literacy/numeracy, Caregiving/relationships, OR Finances Exclusion Criteria: \- Group A and B \-- Patients not continuing care at Dana Farber Cancer Institute

Locations (1)

Dana Farber Cancer Institute

Boston, Massachusetts, United States

Outcomes

Primary Outcomes

Number of Patients Treatment Interruption

Number of interruptions to cancer treatment (defined here as treatment hold, reduction, discontinuation or ED visits/hospitalizations as indicated by the patient medical record)

Time frame: 30 Days

Number of Patients Treatment Interruption

Number of interruptions to cancer treatment (defined here as treatment hold, reduction, discontinuation or ED visits/hospitalizations as indicated by the patient medical record)

Time frame: 90 Days

Number of Patients Treatment Interruption

Number of interruptions to cancer treatment (defined here as treatment hold, reduction, discontinuation or ED visits/hospitalizations as indicated by the patient medical record)

Time frame: 180 Days

Rate of Treatment Interruption

Rate of interruptions to cancer treatment (defined here as treatment hold, reduction, discontinuation or ED visits/hospitalizations as indicated by the patient medical record)

Time frame: 00 Days

Rate of Treatment Interruption

Rate of interruptions to cancer treatment (defined here as treatment hold, reduction, discontinuation or ED visits/hospitalizations as indicated by the patient medical record)

Time frame: 90 Days

Rate of Treatment Interruption

Rate of interruptions to cancer treatment (defined here as treatment hold, reduction, discontinuation or ED visits/hospitalizations as indicated by the patient medical record)

Time frame: 180 Days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.